Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area.
about
Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendationsClinical impact of occult hepatitis B virus infection in immunosuppressed patientsUpdate on occult hepatitis B virus infectionHepatitis B-related events in autologous hematopoietic stem cell transplantation recipients.Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, ChinaOccult HBV infection among Egyptian hepatocellular carcinoma patients.Prevalence of occult hepatitis B virus infectionRituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reportsComparison of real-time PCR assays for monitoring serum hepatitis B virus DNA levels during antiviral therapy.Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma.Infections in hemodialysis: a concise review. Part II: blood transmitted viral infectionsHepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapyOccult HBV infection.Study of the Association of Mutant HBsAg Gene and Hodgkin and Non-Hodgkin Lymphoma.Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation.Hepatitis B virus infection and transfusion medicine: science and the occult.Hepatitis B viremia in completely immunized individuals negative for anti-hepatitis B core antibody.Hepatitis B virus infection: pathogenesis, reactivation and management in hematopoietic stem cell transplant recipients.The association of hepatitis B virus infection with B-cell non-Hodgkin lymphoma - a review.Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for lymphoma: a meta-analysis.Occult HBV infection in the oncohematological setting.Spectrum of hepatitis B and renal involvement.The efficacy of accelerated, multiple, double-dose hepatitis B vaccine against hepatitis B virus infection in cancer patients receiving chemotherapy.Occult Hepatitis Infection in Transfusion Medicine: Screening Policy and Assessment of Current Use of Anti-HBc TestingOccult hepatitis B virus infection: a case of reactivation in a patient receiving immunosuppressive treatment for allogeneic bone marrow transplantation.Outcome of patients with serology suggestive of past hepatitis B virus infection during antitumor necrosis factor therapy for psoriasis.The effects of nucleoside analogue prophylactic treatment on HBV activation in HBcAb+ patients undergoing immunosuppressive therapy.Natural history of patients with recurrent chronic hepatitis C virus and occult hepatitis B co-infection after liver transplantation.Occult hepatitis B virus infection as a cause of posttransfusion hepatitis in patients with cancers.Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier.Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor region.Reflection and observation: cell-based screening failing to detect HBV in HUMSCs derived from HBV-infected mothers underscores the importance of more stringent donor eligibility to reduce risk of transmission of infectious diseases for stem cell-bas
P2860
Q26784247-6B023ED0-6C6C-4B1F-80FC-610730B74608Q27006996-53137C31-3D79-4CA4-A148-E43162BD38DDQ28070317-6811F81C-D8FE-45B9-8DEE-4DB44922CD21Q33782078-8E454C96-2568-4827-973F-8905C82E9AADQ34097882-FF863AD4-CAE7-4C30-AC38-3D034BF2AAEBQ34677661-1E8C63B6-823C-4DE4-9A7A-16C7AEBE1192Q34757367-2D959C39-4F2A-415A-B7ED-16D8849853A1Q34854165-A4BEFFA3-8DC2-4532-BEA8-40E76B70DA51Q35073177-FCCFE3AA-AC1C-4270-A2BA-3BC4012EC906Q35095916-8AE1C8FD-B92F-49CE-8C5C-5632E8D8C4B4Q35532440-30EF8618-1338-4E99-8150-63AB030A1F3CQ35597892-C558B721-D3EE-4678-88AA-B0F1D1A20A3DQ36518847-D6ACAD3F-48EE-4E28-A079-0A23B8250D60Q36542659-9DE56E41-EB11-4BCC-90C4-00A8A2958BCAQ36876536-DC52749E-CAAE-4D33-B265-8A789FABF853Q37153782-E8DAF861-79EF-4002-BE57-EEF1B4E10B41Q37606206-EE1ECEE2-AA23-46AC-AACB-AF434D1D5218Q37942651-87679534-4599-4407-89E9-F9574C2C651CQ37995199-C3BB5718-89DE-4C63-BB70-75CB308147F3Q38375943-CC418D7F-3EC3-4ACC-8984-0AA9AA30C6ECQ38807875-7787B4F6-D509-4C4E-AC70-E757233EBE2BQ39382088-0B39FBB3-F55C-4EA0-8396-578E109F404EQ40924415-9853E39E-7CBE-45FA-861C-574D351877D9Q41111337-09C0AC17-B027-4076-8650-967BA1EA3B6DQ41779103-4329B959-E799-490A-9AAC-2B6145B04547Q42228747-EB2E290D-8F5B-4EB1-A8EE-0E3378F38D8AQ42252692-B5162700-8EFD-4F22-9018-EA1808DA720FQ43001140-525A12F6-AAED-4EA0-897B-8C95068A3D14Q45352097-F6F7A49C-E091-4160-83FE-84BB3A3B8385Q45383263-9073AB1D-4C11-4AA4-AC59-4E4C99F327A5Q45413177-5C5F9C20-8A61-4C1F-AB4A-8C4A1AF4BCE6Q55518637-17019EA7-E369-4350-86CB-59E16FEA8DF3
P2860
Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Occult hepatitis B virus infec ...... epatitis B virus endemic area.
@en
Occult hepatitis B virus infec ...... epatitis B virus endemic area.
@nl
type
label
Occult hepatitis B virus infec ...... epatitis B virus endemic area.
@en
Occult hepatitis B virus infec ...... epatitis B virus endemic area.
@nl
prefLabel
Occult hepatitis B virus infec ...... epatitis B virus endemic area.
@en
Occult hepatitis B virus infec ...... epatitis B virus endemic area.
@nl
P2093
P1476
Occult hepatitis B virus infec ...... hepatitis B virus endemic area
@en
P2093
Albert K W Lie
Chee-kin Hui
George K K Lau
Hai-ying Zhang
Jin-ling Hou
Nikki P Lee
Raymond Liang
Wing-yan Au
Yui-hung Yueng
P304
P356
10.1016/J.JHEP.2005.01.018
P50
P577
2005-03-31T00:00:00Z